Carotenoids Archives - Page 2 of 2

Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration

dev4_5saqdz May 1, 2015 No Comments

Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. (MOST AMD Study)

dev4_5saqdz September 1, 2014 No Comments

Introduction This study explored the effects of supplementing patients with early-stage age-related macular degeneration (AMD) using three different macular carotenoid formulations, lutein, zeaxanthin, and meso-zeaxanthin. The primary focus was not…

Investigation of Genetic Variation in Scavenger Receptor Class B, Member 1 (SCARB1) and Association with Serum Carotenoids

dev4_5saqdz April 1, 2013 No Comments

Secondary Outcomes in a Clinical Trial of Carotenoids with Coantioxidants versus Placebo in Early Age-Related Macular Degeneration

dev4_5saqdz March 1, 2013 No Comments

Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration

dev4_5saqdz December 1, 2012 No Comments

The impact of macular pigment augmentation on visual performance using different carotenoid formulations

dev4_5saqdz November 1, 2012 No Comments

Impact of dietary carotenoid deprivation on macular pigment and serum concentrations of lutein and zeaxanthin: Letter

dev4_5saqdz October 1, 2012 No Comments

Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety — Second Publication in the Series of Meso-Zeaxanthin Ocular Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety. (MOST Trial 2)

dev4_5saqdz November 1, 2011 No Comments

Introduction Following our initial exploratory study, this second MOST study focused on assessing the safety and stability of supplementing with all three macular carotenoids: lutein, zeaxanthin, and meso-zeaxanthin. This research…

The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype

dev4_5saqdz July 1, 2011 No Comments

Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin

dev4_5saqdz October 1, 2004 No Comments

Publication Category: Carotenoids

Sustained supplementation and monitored response with differing carotenoid formulations in early age-related macular degeneration

Supplementation with three different macular carotenoid formulations in patients with early age-related macular degeneration. (MOST AMD Study)

Investigation of Genetic Variation in Scavenger Receptor Class B, Member 1 (SCARB1) and Association with Serum Carotenoids

Secondary Outcomes in a Clinical Trial of Carotenoids with Coantioxidants versus Placebo in Early Age-Related Macular Degeneration

Serum response to supplemental macular carotenoids in subjects with and without age-related macular degeneration

The impact of macular pigment augmentation on visual performance using different carotenoid formulations

Impact of dietary carotenoid deprivation on macular pigment and serum concentrations of lutein and zeaxanthin: Letter

Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety — Second Publication in the Series of Meso-Zeaxanthin Ocular Supplementation with All Three Macular Carotenoids: Response, Stability, and Safety. (MOST Trial 2)

The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype

Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin

Newsletter

Quick Links